Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Diabetes
Clinical Development
Biologics
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Trending T
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Diabetes
Clinical Development
Biologics
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Abiomed
MedTech
J&J CEO says M&A strategy to 'continue' after medtech megadeals
After inking more than $30 billion in M&A within two years, CEO Joaquin Duato said that strategy will continue as it hunts for long-term growth.
Conor Hale
Apr 16, 2024 1:42pm
J&J's Abiomed pump reduces deaths after widowmaker heart attacks
Apr 8, 2024 12:12pm
J&J's Abiomed sees serious Impella recall linked to 49 deaths
Mar 21, 2024 2:29pm
J&J highlights Abiomed’s first year in 2023 medtech earnings
Jan 23, 2024 12:53pm
Johnson & Johnson MedTech head Ashley McEvoy to step down
Oct 24, 2023 9:56am
J&J's Abiomed lands FDA warning letter over Impella heart pumps
Oct 13, 2023 10:42am
